Flat-topped and condylomatous papules in a lung transplant patient

JAMA Dermatology

Volumn 150, Issue 3, 2014, Pages 327-328

  Hoesly, Fridolin ^a   Cappel, Mark ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IMIQUIMOD; PREDNISONE; TACROLIMUS;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONDYLOMA; CRYOTHERAPY; DISEASE ASSOCIATION; EMPHYSEMA; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LUNG TRANSPLANTATION; MEDICAL HISTORY; OUTCOME ASSESSMENT; PAPULE; PRIORITY JOURNAL;

AMINOQUINOLINES; BIOPSY, NEEDLE; COMBINED MODALITY THERAPY; CONDYLOMATA ACUMINATA; CRYOTHERAPY; DIAGNOSIS, DIFFERENTIAL; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOHISTOCHEMISTRY; LUNG TRANSPLANTATION; MIDDLE AGED; RISK ASSESSMENT; THIGH; TRANSPLANTATION IMMUNOLOGY; TREATMENT OUTCOME;

EID: 84896068931     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2013.6332     Document Type: Article

References (10)

1. Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet. 2002;32(4):579-581. (Pubitemid 35435168)
2. Rogers HD, Macgregor JL, Nord KM, et al. Acquired epidermodysplasia verruciformis. J Am Acad Dermatol. 2009;60(2):315-320.
3. Landini MM, Zavattaro E, Borgogna C, et al. Lack of EVER2 protein in two epidermodysplasia verruciformis patients with skin cancer presenting previously unreported homozygous genetic deletions in the EVER2 gene. J Invest Dermatol. 2012;132(4):1305-1308.
4. Kunishige JH, Hymes SR, Madkan V, et al. Epidermodysplasia verruciformis in the setting of graft-versus-host disease. J Am Acad Dermatol. 2007;57(5)(suppl):S78-S80. (Pubitemid 47552637)
5. Barzegar C, Paul C, Saiag P, et al. Epidermodysplasia verruciformis-like eruption complicating human immunodeficiency virus infection. Br J Dermatol. 1998;139(1):122-127. (Pubitemid 28338078)
6. Lutzner M, Croissant O, Ducasse MF, Kreis H, Crosnier J, Orth G. A potentially oncogenic human papillomavirus (HPV-5) found in two renal allograft recipients. J Invest Dermatol. 1980;75(4):353-356. (Pubitemid 10024621)
7. Gómez-Bernal S, Rodríguez-Pazos L, Pereiro-Ferreirós MM, Toribio J. Acquired epidermodysplasia verruciformis in a renal transplant recipient [in Spanish]. Actas Dermosifiliogr. 2011;102(2):159-161.
8. Ko CJ, Iftner T, Barr RJ, Binder SW. Changes of epidermodysplasia verruciformis in benign skin lesions: the EV acanthoma. J Cutan Pathol. 2007;34(1):44-48. (Pubitemid 46066526)
9. Lee KC, Risser J, Bercovitch L. What is the evidence for effective treatments of acquired epidermodysplasia verruciformis in HIV-infected patients? Arch Dermatol. 2010;146(8):903-905.
10. Moore RL, de Schaetzen V, Joseph M, et al. Acquired epidermodysplasia verruciformis syndrome in HIV-infected pediatric patients: prospective treatment trial with topical glycolic acid and human papillomavirus genotype characterization. Arch Dermatol. 2012;148(1):128-130.